I am very excited and proud to announce that the clinical studies conducted on Oxy-Powder were published in the April edition of the International Journal of Pharma and Bio Sciences (IJPBS).
In total, four of the clinical studies conducted on Oxy-Powder were published. Below is a summary of each study.
Oxy-Powder & Constipation
In this clinical study, all patients were suffering from constipation for at least 3 months or more. Routine examination of the patients stool, both before and after the study, indicated no abnormalities. Below are a few summarized bullet-points highlighted in the study:
- 92.6% of the patients in the study had straining during bowel movements on Day 0. Whereas, only 7.7% of patients had this same symptom on Day 42.
- 96.3% of patients passed hard and lumpy stools on Day 0. Whereas, only 7.7% of patients had the same stool consistency on Day 42.
- 55.6% of patients had the sensation of anorectal blockage on Day 0. Whereas, only 3.8% had this same sensation on Day 42 of the study.
- 40.7% of the patients had to perform manuel maneuvers to facilitate a bowel movement. Whereas, on Day 42, 0% of the patients had to perform such maneuvers
The final results indicated:
- 42.3% of the patients treated with Oxy-Powder® had complete remission of constipation.
- 57.7% of the patients treated with Oxy-Powder® had significant improvement.
- Failure rate: 0% in patients treated with Oxy-Powder®.
Thus, efficacy of Oxy-Powder® in treating constipation was significant and efficacious
Continue reading: “Announcement: Oxy-Powder Clinical Studies published in IJPBS”


















